公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
REAGENTE DE HEMÓLISE HBA1C10287410628ROCHE DIAGNÓSTICA BRASIL LTDAII现有
REFERENCE SOLUTION10287410649ROCHE DIAGNÓSTICA BRASIL LTDAI现有
RF CONTROL SET10287410470ROCHE DIAGNÓSTICA BRASIL LTDAII现有
RF-II (Rheumatoid Factors II) - cobas c10287411434ROCHE DIAGNÓSTICA BRASIL LTDAII现有
ROCHE AMONIA/ETANOL/CO2 CALIBRATOR10287410069ROCHE DIAGNÓSTICA BRASIL LTDAIII18/05/2036
ROCHE CARDIAC IQC10287410556ROCHE DIAGNÓSTICA BRASIL LTDAI现有
ROVERS CERVEX BRUSH10287411362ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Rabbit Monoclonal Negative Control Ig10287411753ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Reagentes Genéricos Cobas 4800 System10287411164ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Roche CARDIAC CK-MB10287410750ROCHE DIAGNÓSTICA BRASIL LTDAIII28/07/2033
Roche CARDIAC CK-MB Control10287410724ROCHE DIAGNÓSTICA BRASIL LTDAIII02/06/2033
Roche CARDIAC POC Troponin T 2-Level Control10287411247ROCHE DIAGNÓSTICA BRASIL LTDAIII17/07/2037
Roche Cardiac Poc Troponina10287411111ROCHE DIAGNÓSTICA BRASIL LTDAIII14/09/2035
Roche Cell Collection Medium Kit10287411306ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Rovers® Cervex-Brush10287411557ROCHE DIAGNÓSTICA BRASIL LTDAI现有
S2 FLUID PACK OMNI S10287410150ROCHE DIAGNÓSTICA BRASIL LTDAIII13/10/2036
S3 FLUID PACK OMNI S10287410158ROCHE DIAGNÓSTICA BRASIL LTDAII现有
SALI (Salicylate) - cobas c10287411428ROCHE DIAGNÓSTICA BRASIL LTDAII现有
SAMPLE DILUTION REAGENT II10287410519ROCHE DIAGNÓSTICA BRASIL LTDAI现有
SARS-CoV-2 Antibody Control10287411564ROCHE DIAGNÓSTICA BRASIL LTDAIII08/03/2031
SARS-CoV-2 Antigen Control10287411565ROCHE DIAGNÓSTICA BRASIL LTDAIII08/03/2031
SARS-CoV-2 Antigen Self Test Nasal10287411601ROCHE DIAGNÓSTICA BRASIL LTDAIII13/06/2032
SARS-CoV-2 Extraction Solution10287411561ROCHE DIAGNÓSTICA BRASIL LTDAI现有
SARS-CoV-2 Rapid Antibody Test10287411532ROCHE DIAGNÓSTICA BRASIL LTDAIII17/09/2030
SARS-CoV-2 Rapid Antigen Test10287411536ROCHE DIAGNÓSTICA BRASIL LTDAIII01/10/2030

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家